Oral

Newborn Screening is one of the most successful public health programs in the United States. Over 4 million babies are screened each year for a range of life-altering but treatable conditions such as hearing loss, cystic fibrosis, and sickle cell disease. 2013 marks the 50th anniversary of state-mandated screening. As new technologies, which can give more data earlier in life, emerge and there is more strain on the current public health infrastructure, there has never been such a crucial time for this system. This session will highlight the successes of the past 50 years and discuss the future of screening from the perspectives of multiple stakeholders.

Session Objectives: Delineate between state newborn screening programs and other stakeholder roles Identify three types of conditions detected through newborn screening Summarize key advancements in the past 50 years